Rhinofed

Quick links to important sections

Rhinofed

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rhinofed

What is Rhinofed? (Identity and Purpose)

Property Description
Active ingredient Pseudoephedrine, Terfenadine
Form Tablet, Syrup, Extended-release tablet
Pharmacological class Sympathomimetic Decongestant and H1 Antihistamine
Common use Symptomatic relief of congestion and allergy
Origin Synthetic

Rhinofed is a combination pharmaceutical product designed to provide relief for symptoms related to allergic rhinitis and the common cold. Its core identity is defined by the inclusion of two distinct active ingredients from complementary pharmacological classes. This preparation is typically intended for the oral route of administration.


Rhinofed's Composition: A Synthetic Dual-Active Formula

The function of Rhinofed is delivered by the combination of two International Nonproprietary Names (INN): Pseudoephedrine and Terfenadine. Both of these compounds are synthetic in origin. Pseudoephedrine is categorized as a sympathomimetic agent that acts to relieve congestion, and Terfenadine is classified as an H1 antihistamine.

This dual composition is a key feature, distinguishing it from products with only one active ingredient. The formulation was developed to offer a convenient alternative to taking two separate medications, utilizing the combined power of two pharmacological classes.


General Purpose: Relieving Congestion and Allergic Symptoms

The general purpose of Rhinofed is to achieve integrated symptomatic control across both the physical obstruction and the allergic reaction pathway. The Pseudoephedrine component targets swelling in the nasal and sinus linings to reduce congestion, which is particularly useful in scenarios like seasonal hay fever. Concurrently, the Terfenadine component counters the effects of histamine release, thereby helping to alleviate systemic manifestations of allergic inflammatory conditions, such as sneezing, itching, and rhinorrhea. Such combination decongestant and antihistamine agents are recognized to provide targeted action against multiple cold and allergy symptoms simultaneously.

What side effects are possible with Rhinofed?

Possible side effects and safety information

The official safety profile for Rhinofed, a combination of Pseudoephedrine and Terfenadine, is defined by a range of effects across multiple system-organ classes, as documented in regulatory sources.


Frequency and Organ Systems

Common adverse reactions, primarily linked to the Pseudoephedrine component, include nervousness, insomnia (trouble sleeping), headache, restlessness, and nausea. These effects primarily involve the Nervous System and Gastrointestinal Disorders. Less common reactions listed in regulatory documents include palpitations (irregular heartbeat), dizziness, and dry mouth. The cardiovascular effects associated with the sympathomimetic component also include the potential for hypertension (increased blood pressure).


Serious Adverse Reactions and Constraints

The most critical regulatory concern involves the potential for serious cardiac events associated with the Terfenadine component. The label explicitly documents the risk of life-threatening ventricular tachyarrhythmias, including torsades de pointes, cardiac arrest, and sudden cardiac death. Serious Skin and Subcutaneous Tissue Disorders like Acute Generalised Exanthematous Pustulosis (AGEP) have also been reported rarely with Pseudoephedrine.


Population-Specific and Use Restrictions

Safety is formally constrained for certain populations. Individuals with significant hepatic impairment face a high risk of reduced Terfenadine metabolism, which severely increases the potential for cardiotoxicity. The official label defines strict limitations, noting that use should be avoided in patients with pre-existing conditions such as severe hypertension, coronary artery disease, narrow-angle glaucoma, or conditions leading to urinary tract obstruction. Use is also explicitly restricted alongside certain medications, like Monoamine Oxidase Inhibitors (MAOIs) or potent CYP3A4 inhibitors.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the Rhinofed overdose profile based on severe risks from its components, Pseudoephedrine and Terfenadine. Overdose is characterized by documented signs of Central Nervous System (CNS) excitation and cardiovascular toxicity.

Overdose manifestations may include agitation, restlessness, anxiety, tachycardia, palpitations, and hypertension. The Terfenadine component carries a specific, well-documented risk of life-threatening ventricular arrhythmias, including Torsades de Pointes, which necessitates continuous cardiac monitoring in a hospital setting.

Severe Documented Outcomes Official Emergency Actions
Life-threatening arrhythmias Seek immediate medical attention
Seizures (Convulsions) Contact emergency services immediately
Hypertensive Crisis Hospital observation is required

Immediate medical help must be sought for the sudden onset of symptoms such as seizures, severe headache (thunderclap), collapse, or difficulty breathing, as these reflect severe, documented complications. The official management approach is defined as symptomatic and supportive treatment, as no specific antidote is known for the active ingredients. Regulatory labels note an increased risk of severity in pediatric patients and those with pre-existing cardiovascular conditions.

Therapeutic Uses of Rhinofed

What Rhinofed Treats: Main Uses and Benefits

Rhinofed is a combination product commonly used to help manage the disruptive symptom clusters associated with upper respiratory conditions. This type of product is relevant across domains where short-term symptomatic assistance is needed for allergic reactions and congestion.

It is considered relevant for conditions presenting with acute episodes and recurrent manifestations of Seasonal and Perennial Allergic Rhinitis (hay fever), and is also used for managing common cold or flu symptoms. The medication is commonly used to help with symptom clusters that may become intense or disruptive, including sneezing, runny nose (rhinorrhea), itchiness of the eyes and throat, and symptoms related to physical discomfort, such as nasal and sinus obstruction.

It is often applied in clinical settings that involve acute or unstable symptom patterns, such as during acute or disruptive episodes or when symptoms interfere with daily functioning. This integrated symptomatic relief supports the patient during difficult episodes and contributes to improved comfort during periods of heightened symptoms.

“Applied in scenarios where additional management of discomfort is required, this combination assists with maintaining functional stability when symptoms escalate temporarily.”

Quick Fact: Relief for Dual Symptom Patterns

Rhinofed is relevant for easing symptoms related to inflammatory or irritative states, which supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus overview on combination allergy relief

Eligibility and Restrictions for Use

The official eligibility profile for Rhinofed (Pseudoephedrine/Terfenadine) is defined by strict regulatory limitations and the product's overall status. Most significantly, this combination has been WITHDRAWN from availability in major regulatory regions, including the European Union and the United States, due to the serious risk of cardiac arrhythmias associated with the Terfenadine component.


Absolute Contraindications

For populations where the medicine remains available, its use is absolutely contraindicated in patients with pre-existing severe conditions, including severe hypertension, severe coronary artery disease, severe hepatic disease (liver impairment), and severe renal failure. Individuals taking a Monoamine Oxidase (MAO) Inhibitor or within 14 days of cessation must not use this medicine. Further absolute contraindications include narrow-angle glaucoma and urinary retention.


Population and Age Restrictions

The medicine is not recommended for children under 4 years of age. The extended-release formulation is not recommended for children under 12. Use in pregnant or breastfeeding women is also generally not recommended based on regulatory guidance. Conditional use restrictions apply to geriatric patients and those with milder comorbidities such as diabetes mellitus or hyperthyroidism.

What should I know about interactions with other medicines?

Rhinofed, a combination product containing a decongestant (Pseudoephedrine) and an antihistamine (Triprolidine), has several medically significant interactions that are restricted by regulatory bodies.

Contraindicated and High-Risk Combinations

Monoamine oxidase inhibitors (MAOIs), a class of antidepressants, must not be used concurrently with this medication. A dangerous drug interaction can occur, which may lead to a hypertensive crisis (a sudden, severe increase in blood pressure) due to the presence of Pseudoephedrine. It is essential to avoid using this product if an MAOI, such as isocarboxazid, phenelzine, or tranylcypromine, has been taken within the last 14 days.

Concurrent use with Alcohol is also strongly restricted as the combination can increase the central nervous system (CNS) depressant effects of the antihistamine component, Triprolidine, leading to enhanced drowsiness, dizziness, or impaired alertness.

Other Cautionary Interactions

The antihistamine component may cause additive drowsiness when combined with other central nervous system depressants. This category includes opioid pain relievers, anti-anxiety agents, sedatives, sleeping pills, and some muscle relaxants. Caution is also advised with other anticholinergic drugs, as the combined use may intensify side effects such as dry mouth, blurred vision, or constipation. Patients should also inform their healthcare provider of any other cold, allergy, or cough preparations being used, as these may contain similar ingredients.

Mechanism of Action

Rhinofed contains two active components with distinct pharmacodynamic mechanisms. The first component, pseudoephedrine, is an indirectly acting sympathomimetic amine. It primarily functions as a norepinephrine-releasing agent and inhibitor of the sodium-dependent noradrenaline transporter, increasing synaptic norepinephrine concentration. This elevated norepinephrine level leads to the agonism of alpha1-adrenergic receptors predominantly in the vascular smooth muscle of the nasal mucosa. Receptor activation initiates a downstream cascade resulting in localized vasoconstriction and reduced blood flow to the nasal passage. The second component, triprolidine, is a first-generation histamine H1 receptor antagonist. This molecule competitively binds to and blocks peripheral H1 receptors on target cells in the respiratory and gastrointestinal tract and blood vessels. H1 receptor antagonism prevents endogenous histamine from exerting its effects, thereby modulating histamine-mediated increases in vascular permeability and smooth muscle contraction. The combined system-level physiological consequence involves localized nasal vasoconstriction and the blockade of peripheral histamine effects.

Dosage and Administration Information

How to Use Rhinofed: Administration Guidelines

Rhinofed is a combination product whose usage guidelines are designed to manage the specific release profiles of its active ingredients, Pseudoephedrine and Terfenadine. The primary route of administration is oral.


Administration Protocol and Dosing

The most common formulation used for this combination is an extended-release tablet. The medicine is taken at a fixed frequency to ensure consistent drug levels. For adults and children 12 years of age and older, the standard dosing regimen is one extended-release tablet every 12 hours, resulting in a maximum daily intake of two tablets (corresponding to 240 mg Pseudoephedrine and 120 mg Antihistamine for the successor combination, or 120 mg Terfenadine and 240 mg Pseudoephedrine in historical formulations). This maximum dose should not be exceeded per a 24-hour period.

Special Conditions for Ingestion

The tablet must be swallowed whole and must not be crushed, broken, or chewed, as this compromises the extended-release mechanism. Furthermore, the protocol indicates that the dose be taken on an empty stomach—for instance, one hour before or two hours after a meal—to optimize absorption. It is also a specific administration constraint that the product must not be taken with fruit juices, such as grapefruit or orange juice, which can impact the absorption of the antihistamine component.


Duration and Population Adjustments

Rhinofed is intended for short-term symptomatic relief and should not generally be used for more than seven consecutive days. Dose adjustment is a procedural step for certain populations. Patients with renal impairment (decreased kidney function) have the regimen adjusted to one extended-release tablet once every 24 hours to prevent accumulation of the active ingredients.

Recent Clinical Evidence

Rhinofed: Recent Clinical Evidence

Mechanism of Action

Research investigated the drug’s mechanism of action, which involves two active components: a decongestant (pseudoephedrine) and an antihistamine (triprolidine). The decongestant component acts on blood vessels in the nasal passages, which in studies is associated with reduced swelling of the nasal lining. The antihistamine component is studied for its ability to block histamine, a chemical released by the body during allergic reactions.

Clinical Trial Focus

Clinical trials have evaluated the use of the combination drug in adults experiencing symptoms of seasonal allergic rhinitis (SAR). Studies focused on monitoring changes in specific metrics, including Nasal Airway Resistance (NAR), which measures congestion, and the Hay Fever Symptom Complex Score (HFSCS), which combines symptoms like sneezing, runny nose, and itchy eyes.

Trial Outcomes

Multiple randomized, controlled clinical trials have reported findings regarding symptom changes in participants with SAR. Some large-scale studies reported that participants receiving the combination drug demonstrated lower scores on both NAR (related to nasal congestion) and HFSCS (related to hay fever symptoms) compared to placebo groups. Clinical trials reported changes in symptoms within 24 hours of administration.

Safety and Tolerability

Trial data examined the drug's safety profile, focusing on common adverse events. Adverse events reported in clinical trials were mainly temporary and related to the central nervous system (e.g., drowsiness) due to the antihistamine component, and cardiovascular effects (e.g., mild blood pressure changes) due to the decongestant component. Trial participants generally continued treatment despite these reported events.

Key Studies & References

  1. Triprolidine and pseudoephedrine: Pediatric drug information (Used for safety profile and mechanism of action context)
  2. Label: ED-A-HIST PSE- pseudoephedrine hydrochloride and triprolidine hydrochloride tablet, coated (Regulatory Document / Labeling)

Frequently Asked Questions (FAQ)

Common questions about Rhinofed (FAQ)

Q: How long do the effects of Rhinofed typically last?

A: According to official product information, the extended-release formulation is typically dosed every 12 hours. This frequency is intended to maintain consistent levels of the active ingredients over that period. Some non-extended-release formulations of the components are often dosed every 4 to 6 hours.

Q: Can Rhinofed affect my performance when driving or operating machinery?

A: Official patient advice warns that this medicine may cause drowsiness or impair alertness. Due to these potential central nervous system effects, regulatory documents indicate that individuals should be aware of the need for care and caution when driving a motor vehicle or operating heavy machinery.

Q: What conditions make someone unable to use Rhinofed?

A: Regulatory documents list several absolute contraindications, or conditions that prevent its use. These include severe hypertension (high blood pressure), severe coronary artery disease, severe liver or kidney failure, narrow-angle glaucoma, and urinary retention. Official documentation specifies that the product is contraindicated if a Monoamine Oxidase Inhibitor (MAOI) has been taken within the last 14 days.

Q: Does Rhinofed interact with alcohol?

A: Concurrent use with alcohol is strongly restricted according to official warnings. The combination may result in increased effects from the antihistamine component, such as enhanced drowsiness, dizziness, or impaired alertness.

Q: Does Rhinofed help with sneezing?

A: Yes, the antihistamine component in Rhinofed is described in official sources as helping to alleviate the systemic manifestations of allergic inflammatory conditions. This includes symptoms such as sneezing, itching, and a runny nose.

Q: What are the storage guidelines mentioned in official documents for Rhinofed?

A: Official guidelines require that the product be stored at a controlled room temperature, typically between 20 C and 25 C. The product is required to be protected from excessive heat, light, and moisture and is required to be kept in its original, tightly closed container, out of sight and reach of children.

Q: Is Rhinofed available over the counter?

A: Some forms of the drug are classified as over-the-counter (OTC) products. However, due to the decongestant component (pseudoephedrine), these products are often kept behind the pharmacy counter and subject to quantity limits in many jurisdictions.

Q: Do I need a prescription to get Rhinofed?

A: Whether a prescription is needed depends on the specific formulation and location. In many regions, the product requires a consultation with a pharmacist and government-issued identification for purchase, or a full prescription, because of regulatory controls placed on the pseudoephedrine ingredient.

Q: What types of food or drinks should I avoid while taking Rhinofed?

A: Official regulatory instructions specifically state that the dose is constrained from being taken with fruit juices, including grapefruit or orange juice. This restriction is in place because these juices can negatively impact the absorption of the antihistamine component of the medicine.

Q: Is it safe to drink coffee or caffeine while using Rhinofed?

A: The decongestant component of Rhinofed acts as a stimulant, and nervousness or trouble sleeping are listed among its common reported effects. Combining the medicine with products containing caffeine has the potential to increase the intensity of these stimulant effects.

Q: Can children under 12 use Rhinofed?

A: The extended-release tablet formulation is generally not recommended for use in children under 12 years of age. Regulatory guidance indicates that determination of appropriate use in children under 12 requires consultation with a medical professional.

Q: Is Rhinofed safe for older adults (seniors)?

A: Conditional use restrictions apply to geriatric patients, or adults 65 years of age and older. Regulatory documents indicate that consultation with a doctor is necessary for individuals in this population group to determine if the product is appropriate for their specific health profile.

Q: What are the concerns about using Rhinofed during pregnancy?

A: Use of this medicine in pregnant or breastfeeding women is generally not recommended. Regulatory warnings state that the safety of the active ingredients for use during pregnancy has not been established in clinical studies.

Q: Does Rhinofed have any long-term side effects if used often?

A: Official documents explicitly intend this medicine for short-term symptomatic relief, generally advising against use for more than seven consecutive days. Using the decongestant component for prolonged periods may carry a risk of developing tolerance or dependence.

Q: Why is Rhinofed sometimes kept behind the pharmacy counter?

A: The reason for the restrictions is the pseudoephedrine component. This decongestant ingredient is classified as a controlled precursor chemical, and regulatory bodies track its sale and limit purchases to discourage its use in the illegal manufacture of controlled substances.

Q: Is Rhinofed addictive?

A: Regulatory information indicates that the pseudoephedrine component is chemically similar to stimulants. Non-medical use, particularly at higher doses or for long periods, is associated with a risk of dependence or 'habit-forming' potential.

Q: Does Rhinofed lose its effectiveness over time (tolerance)?

A: The development of tolerance is a reported risk, particularly with the decongestant component of the medicine. Tolerance occurs when a person's body requires a higher amount of the substance to achieve the same initial effect over time.

Q: Is Rhinofed suitable for chronic congestion?

A: Official regulatory guidance intends this medicine for short-term symptomatic relief only. It is not generally advised for chronic congestion, and the prescribed duration of use generally does not exceed seven consecutive days.

Q: Are there studies comparing Rhinofed to placebo?

A: Yes, the clinical trial data reviewed by regulatory bodies includes multiple randomized, controlled studies. These trials evaluated the drug's effects and safety profile by comparing the results of participants who received the drug to those who received a placebo (an inactive substance).

Q: Does taking Rhinofed with food change how it works?

A: Official instructions state that the dose is intended to be taken on an empty stomach—for example, one hour before or two hours after a meal. This constraint is required to optimize the absorption of the antihistamine component, and taking it with food may impact its effectiveness.

Q: What happens if I accidentally take more Rhinofed than recommended?

A: Taking more than the recommended amount of this medicine can result in an overdose. Official safety warnings list symptoms such as severe changes in heartbeat, convulsions, or breathing difficulties. Symptoms of overdose are described as requiring immediate emergency medical attention.

Q: Does Rhinofed interact with herbal supplements?

A: While official documents do not list specific herbal supplements, the general warning against combining it with other central nervous system depressants applies. Caution is advised with any supplement that may increase drowsiness or have anticholinergic effects.

Q: How is the active ingredient in Rhinofed categorized?

A: The two active components belong to two distinct drug classes. One is categorized as a Sympathomimetic Decongestant, which acts on the nervous system to relieve congestion. The other is categorized as an H1 Antihistamine, which blocks histamine to address allergy symptoms.

Q: Is there a maximum number of days I should take Rhinofed?

A: Regulatory guidance explicitly states that this medicine should generally not be used for more than seven consecutive days. If symptoms persist beyond this duration, a medical professional should be consulted.

Q: Are there different strengths or formulations of Rhinofed?

A: Official product information documents show that the medicine has been available in various forms and strengths. These formulations include tablets, extended-release tablets, and syrup, each containing specific milligram amounts of the active ingredients.

Q: Why do official documents list certain populations who cannot use Rhinofed?

A: Official documents list these restrictions because of the potential for serious adverse reactions. Risks include life-threatening heart rhythm issues (ventricular tachyarrhythmias) associated with the antihistamine component and an increased risk of dangerously high blood pressure (hypertensive crisis) related to the decongestant component in certain patients.

Q: Are there known interactions between Rhinofed and common cold remedies?

A: The official label advises caution regarding other cold remedies. This is because many of these preparations may contain similar active ingredients (such as other decongestants or antihistamines), which could increase the risk of side effects or overdose.

Q: Is it true that Rhinofed can affect urine tests?

A: Yes, the decongestant component, pseudoephedrine, is chemically similar to certain stimulant compounds. Official information notes that this may yield a non-negative (sometimes called a false positive) result for amphetamines on some initial drug screening or urine tests.

Q: Why is detailed information about Rhinofed difficult to find online?

A: The combination of active ingredients, particularly Terfenadine, was officially WITHDRAWN from availability in major regulatory markets due to the serious, documented risk of cardiac arrhythmias. This withdrawal is the reason why detailed, current information may be limited or difficult to find in many drug databases.

Q: Is there any research on Rhinofed use in adolescents?

A: While most clinical trials focused on adults, regulatory information addresses use in the adolescent population. Dosing information for children aged 12 years and older is sometimes provided, aligning with the restrictions placed on younger children.

How should Rhinofed be stored and disposed of?

How to Store and Dispose of Rhinofed

The storage and disposal of Rhinofed (Fexofenadine/Pseudoephedrine) must follow specific regulatory requirements to ensure its stability and public safety.

Storage Conditions

Condition Requirement
Temperature Store at controlled room temperature, between 20 C to 25 C (68 F to 77 F).
Environment Protect from excessive heat, light, and moisture; do not store in the bathroom.
Packaging Keep in the original, tightly closed container; do not use if blister units are torn.
Child Safety Keep out of sight and reach of children at all times.

Disposal Instructions

Unused or expired product should be discarded according to official governmental guidance. This requires utilizing drug take-back programs or following the FDA's recommended household disposal method: mixing the medicine with an undesirable substance (e.g., coffee grounds) and placing it in a sealed container before disposal in the trash. The product should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rhinofed found in:

A-Z Index: